XCORP

## XCORP LLC

Logo since 2022, designed by The Mackerel Group

XCORP Headquarters in Bloxburg

**XCORP LLC** *(previously known as The X Corporation)* is a multinational pharmaceutical and biotechnology conglomerate headquartered in Bloxburg, founded in 1990.

The company started by offering DNA and biological data analysis, and expanded into their own biological research and development of vaccines, medicines, and essential medical equipment. XCORP is known for its revolutionary scientific breakthrough in cancer treatment in 1996. In 1998, XCORP established a manufacturing division, producing surgical tools, patient monitors, personal protective equipment, and more.

XCORP was reincorporated in 2023 after their original Articles of Incorporation were compromised. The company has had several other controversies, including an FBI probe from 2007 to 2011, and Cian Stursix's departure in 2003, who was a co-founder and COO of the company.

## History

### 1990-1996: Early years and breakthrough

X Corporation was founded on December 1st, 1990, by Jacob Finance with support from early business partner Cian Stursix.

They started by providing DNA testing services using a lab built in Jacob's garage, offering their services mostly to men who were concerned about their paternity. Due to their astronomical margins, they were quickly able to expand into a professional laboratory in June 1991, and later in the year hire several scientists to increase their productivity.

XCORP, now gaining solid ground in the DNA testing industry, expanded into offering biological data analysis (ex. blood testing), in early 1992.

In early-mid 1992, XCORP decided to start offering a service to analyze a human's ancestral background. This service was sold under the brand name "AncXstry". Notable clients of AncXstry include Freddy.

XCORP prided themselves on accuracy; Consumer reports' June 1993 issue reported that the company had the lowest false positive/negative rate in the industry. And with their newfound reputation, and the success of AncXstry, decided in November 1993 to lease a new lab facility and expanded into doing their own research and development for pharmaceuticals, vaccines, and medicines.

On January 20th, 1995, XCORP made an Initial Public Offering on the New York Stock Exchange, under the ticker "XC". XCORP offered 100,000,000 shares, and closed at a price of $12.90 per share, imputing a valuation of $1.29 billion.

On April 30th, 1996, XCORP announced they had completed development of a revolutionary cancer treatment, that saw a 98% survival rate during clinical trials. News of this advancement shook the industry. Shares of cancer treatment industry leaders such as Regeneron, Amgen Inc, and Gilead Sciences fell as much as 80%. Gilead later filed for bankruptcy, and liquidated.

### 1997-2003: Rise to industry fame, with a cost

On January 2nd, 1997, XCORP released their revolutionary cancer treatment to the market. Sold under the name "**CellBlaster**".
Being relatively cheap compared to traditional cancer treatments, $10,000 vs $150,000 on average, CellBlaster completely dominated the cancer treatment industry by the end of 1997, with an estimated 78% market share of the cancer treatment industry, and climbing.

In the summer of 1997, XCORP, now trading at over $3000 per share, announced a 10-for-1 stock split. On the day of the split, XCORP was up 30% at the time of closing, at $390 per share, imputing a valuation of $390 billion.

In 2001, Jacob Finance personally hired Brad Marchand as an accountant to XCORP.

Sometime in 2002, 1 unidentified lab worker and Co-founder and COO Cian Stursix were severely injured in a lab accident, the lab worker was killed instantly, and Cian sustained 2nd and 3rd degree burns to 60% of his body, and eventually, they believed he made a full recovery.

Cian's behavior began to change since the accident, becoming more erratic and aggressive, potentially due to an undiagnosed Traumatic Brain Injury stemming from the accident. Cian ended up leaving the company in July 2003 when he and Jacob got into a violent dispute.

To fill the void created by Cian's sudden departure, in August 2003, CEO Jacob promoted top-level accountant Brad Marchand to CFO.

### 2004-2010: Continued success and FBI inquiry

In February 2004, Total sales of CellBlaster surpassed $1 trillion.

In May of 2006, XCORP completed the construction of CS Hospital, which became a life-saving success for Bloxburg, along with a major financial success for XCORP. Because XCORP manufactures it's own medicines and treatments, the hospital's margins were astronomical. CS Hospital also has saved countless lives due to utilization of XCORP's advanced treatments, and sometimes offering high-risk, high-reward experimental treatments. CS Hopsital holds the Bloxburg record for the most babies delivered at a single hospital.

In 2007, the FBI opened a case against XCORP, investigating alleged involvement with the New York Mafia's Delucci Family and Colombia's Cartegena Cartel, corporate warfare acts, such as allegedly running a secret "Clean-up Crew" which allegedly had been used to sabotage property of other companies and assassinate people who were seen as threats to XCORP's power.

In 2009, several XCORP Employees, including Jacob Finance, Brad Marchand, John Alcantara, and Hal Hanover were arrested and charged in a federal court under a joint indictment which included 9 counts of capital murder, 30 counts of burglary, 34 counts of grand larency, 102 counts of destruction of private property, and 2048 antitrust violations.

### 2011-2017: Charges dropped and limited advancements

On December 11th, 2011, all charges against XCORP Employees were dropped when tragically, a bus containing all of the prosecution's 30 witnesses, on the way to the courthouse, reportedly swerved to avoid hitting a fish on the road, lost control, tragically fell off a 400 foot cliff, and exploded 6 times, none of the passengers survived as the bus was completely reduced to rubble. With no witnesses, the prosecution had no case, and was forced to drop all charges, and the FBI closed their case.

Nearing the end of the investigation, XCORP reached it's worst financial state in years. A combination of the 2008 financial crisis and the controversy surrounding the indictment were the main contributing factors.

Jacob Finance immediately got back to work and ordered XCORP's scientists to "find something new and change the world". However, the company wouldn't see a major increase in success until in 2013 when XCORP released a medical-grade painkiller known as "Passiton", which was praised by doctors to due being minimally addictive, yet regarded by many to be the strongest pain reliever in the world.

In August 2016, former COO Cian Stursix, after being missing for 13 years, resurfaced and wished to make amends with Jacob. Jacob welcomed him back with open arms, and reappointed him COO. This would be short lived as in October 2017, Cian attempted to murder Jacob.

### 2018-ongoing: The Golden Years

When the Covid-19 pandemic hit, XCORP, under President Donald J. Trump's Operation Warp Speed, began developing it's Covid-19 Vaccine candidate, which surprisingly, would fail to be effective enough to advance, at only 22% effectiveness. XCORP has since criticized the other manufacturers in the program for withholding information about their vaccines side effects, and the actual effectiveness of the vaccines against the virus. A study conducted by a group of XCORP scientists hand picked by Jacob, supposedly shows that "people who have received a Covid-19 vaccination do not receive any protection from the new variants, and in many cases, actually increases your rate of infection." and that "the Covid-19 vaccines have abnormally high chances of severe side effects when compared to *other vaccines*." in conclusion, the report noted that "The risks of receiving a Covid-19 vaccination far outweigh the benefits." The report received severe backlash from major news networks such as CNN, MSNBC, CBS, and ABC, baselessly calling the report a "disinformation campaign". While networks such as Fox News, Newsmax, and OANN, praised the report. BNC provided a neutral viewpoint.

On January 4th, 2023, according to filings made with numerous agencies such as the SEC, IRS, USDC, and FTC, CEO Jacob Finance formed XCORP LLC, and initiated an immediate transfer of assets from The X Corporation to the newly formed LLC. On January 5th, 2023, an FTC-supervised shareholders meeting was held at XCORP HQ in which the major shareholders unanimously approved the transfer of assets. At a press conference shortly after the meeting, Jacob Finance stated that the reorganization was due to "our original articles of incorporation being compromised", but did not state how or why this had occurred. At a January 7th, 2023 press conference, from which Jacob was absent, Chief of Staff Niraj Takia stated that the transfer of assets had been completed.

In February 2023, Claire Elrod was instated as Acting CFO due to Brad Marchand being absent and XCORP being assigned a strict tax deadline.

On September 11th, 2023, longtime CFO Brad Marchand committed suicide. Marchand shot himself in the chest and fell from the roof of Stratton-Oakmont HQ. Dying on his birthday, he was 43 years old.

## Products and Services

### Services

AncXstry
CS Hospital
Xscort

## Key people & Owners

### Key people (in hierarchal order)

Chairman of the Board
David Syske (Since 2023)

Chief Executive Officer

Executive Chief of Staff

Chief Operations Officer

Chief Financial Officer
 Vacant
 Claire Elrod | *(Acting)* Since Feb. 3rd 2023

Chief Information Officer

Director of Security
 Владислав Михайлов
 Max Slay | Jul. 27th, 2021 - Jan. 2nd, 2023
 Aleksandre Shiedeski | Since Jan. 2nd, 2023

Director of Afghan-Central Asia Operations
Taha Jasor (2000-2011)

## Controversies & Legal issues

### 2007-2011 FBI Probe

In 2007, the FBI opened a case against XCORP, investigating alleged involvement with the New York Mafia's Delucci Family and Colombia's Cartegena Cartel, corporate warfare acts, such as allegedly running a secret "Clean-up Crew" which allegedly had been used to sabotage property of other companies and assassinate people who were seen as threats to XCORP's power.

In 2009, several XCORP Employees, including Jacob Finance, Brad Marchand, John Alcantara, and Hal Hanover were arrested and charged in a federal court under a joint indictment which included 9 counts of capital murder, 30 counts of burglary, 34 counts of grand larency, 102 counts of destruction of private property, and 2048 antitrust violations.

On December 11th, 2011, all charges against XCORP Employees were dropped when tragically, a bus containing all of the prosecution's 30 witnesses, on the way to the courthouse, reportedly swerved to avoid hitting a fish on the road, lost control, tragically fell off a 400 foot cliff, and exploded 6 times, none of the passengers survived as the bus was completely reduced to rubble. With no witnesses, the prosecution had no case, and was forced to drop all charges, and the FBI closed their case.

### 2023 Reincorporation

On January 4th, 2023, according to filings made with numerous agencies such as the SEC, IRS, USDC, and FTC, CEO Jacob Finance formed XCORP LLC, and initiated an immediate transfer of assets from The X Corporation to the newly formed LLC. On January 5th, 2023, an FTC-supervised shareholders meeting was held at XCORP HQ in which the major shareholders unanimously approved the transfer of assets. At a press conference shortly after the meeting, Jacob Finance stated that the reorganization was due to "our original articles of incorporation being compromised", but did not state how or why this had occurred. At a January 7th, 2023 press conference, from which Jacob was absent, Chief of Staff Niraj Takia stated that the transfer of assets had been completed.

1. ↑ Reincorporated as XCORP LLC on January 4th, 2023
2. ↑ Missing in action May 13th, 2022 until July 21st, 2022; currently under a *Leave of Absence*
3. ↑ 3.0 3.1 3.2 Private Equity Owner before the company's January 20th, 1995 IPO